"
A Proof-of-Concept Assessment of the Safety and Efficacy of Intralesional Diclofenac in the Treatment of Cutaneous Neurofibromas"
written by Mauro Geller, Aguinaldo Bonalumi Filho, Lisa Oliveira, Allan E. Rubenstein, Luiz Guilherme Darrigo Jr., David Azulay, Allan Bernacchi, Marcia Gonçalves Ribeiro, Karin Soares Gonçalves Cunha,
published by
International Journal of Clinical Medicine,
Vol.6 No.12, 2015
has been cited by the following article(s):
|
[1]
|
Ex Vivo Patient-Derived Explant Model for Neurofibromatosis Type 1–Related Cutaneous Neurofibromas
Journal of Investigative Dermatology,
2024
DOI:10.1016/j.jid.2024.01.032
|
|
|
|
|
[2]
|
Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1
Heliyon,
2021
DOI:10.1016/j.heliyon.2021.e06518
|
|
|
|
|
[3]
|
Management of cutaneous neurofibroma: current therapy and future directions
Neuro-Oncology Advances,
2019
DOI:10.1093/noajnl/vdz034
|
|
|
|
|
[4]
|
Cutaneous neurofibromas in the genomics era: current understanding and open questions
British Journal of Cancer,
2018
DOI:10.1038/s41416-018-0073-2
|
|
|
|